
- February 2015 Autoimmune Disorders
- Volume 81
- Issue 2
The Critical Role of Pharmacists in Management and Adherence of Glaucoma Therapy
This continuing education activity is supported by an unrestricted educational grant from Alcon, Inc.
This activity is supported by an unrestricted educational grant from Alcon, Inc.
The Critical Role of Pharmacists in Management and Adherence of Glaucoma Therapy
Faculty
Jamie Rickards, PharmD, MBA, BCPS
Assistant Professor
Clinical & Administrative Sciences
Notre Dame of Maryland University
School of Pharmacy
Baltimore, Maryland
Michelle A. Fritsch, PharmD, CGP, BCACP
Professor and Chair
Clinical & Administrative Sciences
Notre Dame of Maryland University
School of Pharmacy
Baltimore, Maryland
Educational Objectives
After participating in this activity, participants should be able to:
- Demonstrate knowledge of the risk factors, pathophysiology, and etiology of the different types of glaucoma.
- Define the mechanism of action as well as safety and efficacy profiles of the different treatment classes and individual agents available for the management of glaucoma.
- Educate patients on proper administration and scheduling of their eye drops, as well as the importance of treatment adherence.
Target audience:
Pharmacists
Type of activity:
Knowledge
Release date:
January, 23, 2015
Expiration date:
January, 23, 2017
Estimated time to complete activity:
2.0 hours
Pharmacy Times Office of Continuing Professional Education is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education.
This activity is approved for 2.0 contact hours (0.20 CEUs) under the ACPE universal activity number 0290-0000-15-011-H01-P. The activity is available for CE credit through January 28, 2017.
Articles in this issue
almost 11 years ago
New Drugs of 2014: Part 2almost 11 years ago
Can You Read These Rxs? (February 2015)almost 11 years ago
Case Studies (February 2015)almost 11 years ago
Pet Peeves (February 2015)almost 11 years ago
RSV Infection May Be Connected to Increased Pneumonia Riskalmost 11 years ago
Testosterone May Prove an Unlikely Ally in Fight Against Prostate Canceralmost 11 years ago
Vaccine Therapy Shows Promise in Prostate Cancer Patientsalmost 11 years ago
Flu Vaccine Provides Weaker Protection This Seasonalmost 11 years ago
Immune Response to Rhinovirus Suppressed in Colder Temperaturesalmost 11 years ago
New Genetic Test Predicts Prostate Cancer Recurrence Risk with 80% AccuracyNewsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.

















































































































































































































